Use of Physiology to Evaluate Procedural Result After PCI CTO
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIsala
About this trial
ULTRA-CTO is a prospective multicentre non-randomised investigator-initiated trial designed to enrol 200 subjects with an indication for percutaneous coronary intervention (PCI) of chronic total occluded (CTO) coronary artery.
The main objective of the study is to assess the predictive value of post-PCI resting full-cycle ratio (RFR) and fractional flow reserve (FFR) with regard to Fractional flow reserve (SSR) in CTO patients.
Eligibility criteria
Qualifiers
Age 18 years and older.
Angiographically successful PCI CTO without any remaining lesion at least 30% proximal to the stented segment.
Possibility to perform physiologic measurements and OCT of sufficient quality.
Patients willing and capable to provide written informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- post-PCI Pd/Pa
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Isala
Lead sponsor
Abbott
Collaborator
Source ClinicalTrials.gov